Sanofi

ANZEMET

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Sanofi

Anzemet HCPCS:

J1260

HCPCS Code Descriptor:

Injection, dolasetron mesylate, 10 mg

Category:

J Code

Anzemet NDCs:

No actively aligned NDCs found

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Anzemet CPT Codes:

Potential CPT administration codes for Anzemet can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Anzemet:

ANZEMET is an Oncology-Anti-Emetic drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J1260 is aligned to the drug ANZEMET.

ACCESS PRICING AND MORE BY REGISTERING

J1260 Added Date:

January 1, 1999

J1260 Effective Date:

January 1, 2000

J1260 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Anzemet billing and coding information.
Our team did not identify a source for Anzemet patient assistance information. Please reach out to our team if you feel that this is a mistake.
ANZEMET prescribing information can be found at the link below:
Information regarding ANZEMET’s side effects can be found at MedlinePlus